Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Influenza

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 181 articles:
HTML format
Text format



Single Articles


    July 2019
  1. SHI N, Huang J, Zhang X, Bao C, et al
    Interventions in live poultry markets for the control of avian influenza: A systematic review and meta-analysis.
    J Infect Dis. 2019 Jul 17. pii: 5533237. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. VENKATESAN S, Myles PR, Bolton KJ, Muthuri SG, et al
    Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.
    J Infect Dis. 2019 Jul 17. pii: 5533434. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. UEHARA T, Hayden FG, Kawaguchi K, Omoto S, et al
    Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.
    J Infect Dis. 2019 Jul 16. pii: 5532607. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. LU Y, Chillarige Y, Izurieta HS, Wei Y, et al
    Effect of age on relative effectiveness of high-dose versus standard-dose influenza vaccines among US Medicare beneficiaries ages 65 years and older.
    J Infect Dis. 2019 Jul 9. pii: 5530548. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. CHUA H, Chiu SS, Chan ELY, Feng S, et al
    Effectiveness of partial and full influenza vaccination in children aged <9 years in Hong Kong, 2011-2019.
    J Infect Dis. 2019 Jul 9. pii: 5530568. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. SHORT KR, Kuiken T, van Riel D
    The role of endothelial cells in the pathogenesis of influenza in humans.
    J Infect Dis. 2019 Jul 8. pii: 5529824. doi: 10.1093.
    PubMed     Text format    


  7. JIA W, Wen X, Xie S, Dai Y, et al
    A Novel Antigenic Drift of Avian Influenza A(H7N9) Virus in Poultry, China, 2018.
    J Infect Dis. 2019 Jul 8. pii: 5529482. doi: 10.1093.
    PubMed     Text format    


  8. NG TWY, Perera RAPM, Fang VJ, Yau EM, et al
    The effect of influenza vaccination history on changes in hemagglutination inhibition titers following receipt of the 2015/16 influenza vaccine in older adults in Hong Kong.
    J Infect Dis. 2019 Jul 6. pii: 5529474. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2019
  9. LARTEY S, Zhou F, Brokstad KA, Mohn KG, et al
    Live attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction.
    J Infect Dis. 2019 Jun 27. pii: 5524503. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. ZHONG W, Levine MZ
    Stockpiled avian influenza A(H7N9) vaccines induce robust, non-neutralizing functional antibodies against antigenically drifted 5th wave A(H7N9) viruses.
    J Infect Dis. 2019 Jun 5. pii: 5511958. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2019
  11. GREGIANINI TS, Varella IRS, Fisch P, Martins LG, et al
    Dual and Triple Infections With Influenza A and B Viruses: A Case-Control Study in Southern Brazil.
    J Infect Dis. 2019 May 29. pii: 5481580. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. REDLBERGER-FRITZ M, Vietzen H, Puchhammer-Stockl E
    Association of severe influenza virus infections with CD226 (DNAM-1) variants.
    J Infect Dis. 2019 May 21. pii: 5494791. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. MARTINEZ-BAZ I, Navascues A, Casado I, Aguinaga A, et al
    Remaining effect of influenza vaccines received in prior seasons.
    J Infect Dis. 2019 May 20. pii: 5492310. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. MURRAY AF, Englund JA, Kuypers J, Tielsch JM, et al
    Infant pneumococcal carriage during influenza, RSV and hMPV respiratory illness within a maternal influenza immunization trial.
    J Infect Dis. 2019 May 6. pii: 5485855. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. BUDD AP, Beacham L, Smith CB, Garten RJ, et al
    Birth Cohort Effects in Influenza Surveillance Data: Evidence that First Influenza Infection Affects Later Influenza-Associated Illness.
    J Infect Dis. 2019 May 3. pii: 5485579. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. AMOAH S, Mishina M, Praphasiri P, Cao W, et al
    Standard dose intradermal influenza vaccine elicits similar cellular immune responses when compared to intramuscular vaccine in HIV-infected or uninfected men.
    J Infect Dis. 2019 May 2. pii: 5482500. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2019
  17. AMBIGAPATHY G, Schmit T, Mathur RK, Nookala S, et al
    Double-Edged Role of Interleukin 17A in Streptococcus pneumoniae Pathogenesis During Influenza Virus Coinfection.
    J Infect Dis. 2019 Apr 23. pii: 5476446. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. CHAN LLY, Hui KPY, Kuok DIT, Bui CHT, et al
    Risk assessment of the tropism & pathogenesis of the highly pathogenic avian influenza A/H7N9 virus using ex vivo & in vitro cultures of human respiratory tract.
    J Infect Dis. 2019 Apr 18. pii: 5475154. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2019
  19. ROOT JJ
    What Are the Transmission Mechanisms of Influenza A Viruses in Wild Mammals?
    J Infect Dis. 2019 Mar 6. pii: 5369377. doi: 10.1093.
    PubMed     Text format    


  20. SOILEMETZIDOU ES, De Bruin E, Franz M, Aschenborn OHK, et al
    Diet May Drive Influenza A Virus Exposure in African Mammals.
    J Infect Dis. 2019 Mar 6. pii: 5369376. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2019
  21. THORNTON AC, Parry-Ford F, Tessier E, Oppilamany N, et al
    Human exposures to H5N6 Avian influenza, England, 2018.
    J Infect Dis. 2019 Feb 21. pii: 5351024. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. FU Y, Durrwald R, Meng F, Tong J, et al
    Infection Studies in Pigs and Porcine Airway Epithelial Cells Reveal an Evolution of A(H1N1)pdm09 Influenza A Viruses Toward Lower Virulence.
    J Infect Dis. 2019 Feb 18. pii: 5334094. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. ZELNER J, Petrie JG, Trangucci R, Martin ET, et al
    Effects of sequential influenza A(H1N1)pdm09 vaccination on antibody waning.
    J Infect Dis. 2019 Feb 4. pii: 5306487. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. LEVINE MZ, Martin ET, Petrie JG, Lauring AS, et al
    Antibodies against egg- and cell-grown influenza A(H3N2) viruses in adults hospitalized during the 2017-2018 season.
    J Infect Dis. 2019 Feb 4. pii: 5306481. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2019
  25. PAULES CI, Fauci AS
    Influenza Vaccines: Good, But We Can Do Better.
    J Infect Dis. 2019 Jan 31. pii: 5304932. doi: 10.1093.
    PubMed     Text format    


  26. SAAD-ROY CM, McDermott AB, Grenfell BT
    Dynamic perspectives on the search for a universal influenza vaccine.
    J Infect Dis. 2019 Jan 31. pii: 5304934. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. CRANK MC, Mascola JR, Graham BS
    Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    J Infect Dis. 2019 Jan 31. pii: 5304928. doi: 10.1093.
    PubMed     Text format    


  28. RUDRARAJU R, Mordant F, Subbarao K
    How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304927. doi: 10.1093.
    PubMed     Text format    


  29. ROSS TM
    Universal Influenza Vaccine Approaches Employing Full-Length or Head-only HA Proteins.
    J Infect Dis. 2019 Jan 31. pii: 5304925. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. SANT AJ
    The way forward: Potentiating protective immunity to novel and pandemic influenza through engagement of memory CD4 T cells.
    J Infect Dis. 2019 Jan 31. pii: 5304931. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. CROWE JE JR
    Antibody Determinants of Influenza Immunity.
    J Infect Dis. 2019 Jan 31. pii: 5304924. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. NEUMANN G, Kawaoka Y
    Can We Predict The Next Influenza Pandemics?
    J Infect Dis. 2019 Jan 31. pii: 5304929. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. SAELENS X
    The Role of M2e in the Development of Universal Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304896. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. EICHELBERGER MC, Monto AS
    Neuraminidase, the forgotten surface antigen, emerges as an influenza vaccine target for broadened protection.
    J Infect Dis. 2019 Jan 31. pii: 5304892. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. KRAMMER F, Palese P
    Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain.
    J Infect Dis. 2019 Jan 31. pii: 5304926. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. MORENS DM, Taubenberger JK
    Making Universal Influenza Vaccines: Lessons from the 1918 Pandemic.
    J Infect Dis. 2019 Jan 31. pii: 5304851. doi: 10.1093.
    PubMed     Text format    


  37. ORTIZ JR, Neuzil KM
    Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304930. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. PRASAD N, Huang QS, Wood T, Aminisani N, et al
    Influenza associated outcomes among pregnant, post-partum, and non-pregnant women of reproductive age.
    J Infect Dis. 2019 Jan 23. pii: 5299596. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2018
  39. LAUZON-JOSET JF, Scott NM, Mincham KT, Stumbles PA, et al
    Pregnancy induces a steady-state shift in alveolar macrophage M1/M2 phenotype that is associated with a heightened severity of Influenza infection: mechanistic insight using mouse models.
    J Infect Dis. 2018 Dec 21. pii: 5257349. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. HOWARD LM, Goll JB, Jensen TL, Hoek KL, et al
    AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures In Human Peripheral Blood Mononuclear Cells.
    J Infect Dis. 2018 Dec 19. pii: 5253567. doi: 10.1093.
    PubMed     Text format     Abstract available


  41. FLANNERY B, Fry AM
    Comparing influenza vaccine types: the path towards improved influenza vaccine strategies.
    J Infect Dis. 2018 Dec 18. pii: 5250956. doi: 10.1093.
    PubMed     Text format    


  42. IZURIETA HS, Chillarige Y, Kelman J, Wei Y, et al
    Relative effectiveness of cell-cultured and egg-based influenza vaccines among the U.S. elderly, 2017-18.
    J Infect Dis. 2018 Dec 18. pii: 5250955. doi: 10.1093.
    PubMed     Text format     Abstract available


  43. NG TWY, Cowling BJ, Gao HZ, Thompson MG, et al
    Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis.
    J Infect Dis. 2018 Dec 14. pii: 5247419. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. KEITEL WA, Atmar RL
    Influenza Vaccines after Seven Decades: Still on the Learning Curve.
    J Infect Dis. 2018 Dec 14. pii: 5248489. doi: 10.1093.
    PubMed     Text format    


  45. FERDINANDS JM, Gaglani M, Martin ET, Middleton D, et al
    Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    J Infect Dis. 2018 Dec 14. pii: 5248488. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. COHEN C, Tshangela A, Valley-Omar Z, Iyengar P, et al
    Household transmission of seasonal influenza from HIV-infected and -uninfected individuals in South Africa, 2013-2014.
    J Infect Dis. 2018 Dec 12. pii: 5240968. doi: 10.1093.
    PubMed     Text format     Abstract available


  47. ZOST SJ, Wu NC, Hensley SE, Wilson IA, et al
    Immunodominance and antigenic variation of influenza virus hemagglutinin: implications for design of universal vaccine immunogens.
    J Infect Dis. 2018 Dec 9. pii: 5236836. doi: 10.1093.
    PubMed     Text format    


  48. JENNIFER R, Green WD, Alwarawrah Y, Nichols AG, et al
    Obesity-induced changes in T cell metabolism are associated with impaired memory T cell response to influenza and are not reversed with weight loss.
    J Infect Dis. 2018 Dec 9. pii: 5236852. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2018
  49. SANYAL M, Holmes TH, Maecker H, Albrecht RA, et al
    Diminished B-cell response after repeat influenza vaccination.
    J Infect Dis. 2018 Nov 28. pii: 5212478. doi: 10.1093.
    PubMed     Text format     Abstract available


  50. LEE N, Ison MG
    Inhibiting Viral Polymerase and Neuraminidase in Treating Influenza.
    J Infect Dis. 2018 Nov 14. pii: 5183287. doi: 10.1093.
    PubMed     Text format    


  51. FINBERG RW, Lanno R, Anderson D, Fleischhackl R, et al
    Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial.
    J Infect Dis. 2018 Nov 14. pii: 5183286. doi: 10.1093.
    PubMed     Text format     Abstract available


  52. POIROT E, Levine MZ, Russell K, Stewart RJ, et al
    Detection of Avian Influenza A(H7N2) Virus Infection Among Animal Shelter Workers Using a Novel Serological Approach-New York City, 2016-2017.
    J Infect Dis. 2018 Nov 5. pii: 5161222. doi: 10.1093.
    PubMed     Text format     Abstract available


  53. JAIN S, Murray EL
    The Cat's Meow: Using Novel Serological Approaches to Identify Cat-to-Human Influenza A(H7N2) Transmission.
    J Infect Dis. 2018 Nov 3. pii: 5159540. doi: 10.1093.
    PubMed     Text format    


    September 2018
  54. SCHELLER N, Herold S, Kellner R, Bertrams W, et al
    Pro-viral miRNAs detected in BALF extracellular vesicles of patients with influenza virus-induced ARDS.
    J Infect Dis. 2018 Sep 15. pii: 5098403. doi: 10.1093.
    PubMed     Text format     Abstract available


  55. L'HUILLIER AG, Ferreira VH, Hirzel C, Cordero E, et al
    Cytokine Profiles and Severity of Influenza Infection in Transplant Recipients.
    J Infect Dis. 2018 Sep 5. pii: 5091250. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. MORI I
    1918 H1N1 Influenza Virus Infection-Induced Proinflammatory Cytokines in the Olfactory Bulb Could Trigger Lethargic Disease.
    J Infect Dis. 2018 Sep 4. pii: 5090304. doi: 10.1093.
    PubMed     Text format    


    August 2018
  57. MAIER HE, Lopez R, Sanchez N, Ng S, et al
    Obesity Increases the Duration of Influenza A Virus Shedding in Adults.
    J Infect Dis. 2018 Aug 2. pii: 5051913. doi: 10.1093.
    PubMed     Text format     Abstract available


  58. LOY H, Kuok DIT, Hui KPY, Choi MHL, et al
    Therapeutic implications of human umbilical cord mesenchymal stromal cells in attenuating influenza A/H5N1-associated acute lung injury.
    J Infect Dis. 2018 Aug 2. pii: 5064213. doi: 10.1093.
    PubMed     Text format     Abstract available


  59. SCHULTZ-CHERRY S
    Beyond Disease Severity: The Impact of Obesity on Influenza A Virus Shedding.
    J Infect Dis. 2018 Aug 2. pii: 5051914. doi: 10.1093.
    PubMed     Text format    


    July 2018
  60. YOGARATNAM J, Rito J, Kakuda TN, Fennema H, et al
    Antiviral Activity, Safety, and Pharmacokinetics of AL-794, a Novel Oral Influenza Endonuclease Inhibitor: Results of an Influenza Human Challenge Study.
    J Infect Dis. 2018 Jul 26. pii: 5060129. doi: 10.1093.
    PubMed     Text format     Abstract available


  61. TREANOR J
    Influenza Challenge and the Challenge of Drug Development.
    J Infect Dis. 2018 Jul 26. pii: 5060130. doi: 10.1093.
    PubMed     Text format    


  62. HUANG QS, Bandaranayake D, Wood T, Newbern EC, et al
    Risk factors and attack rates of seasonal influenza infection: results of the SHIVERS seroepidemiologic cohort study.
    J Infect Dis. 2018 Jul 17. pii: 5054657. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. COWLING BJ, Sullivan SG
    The value of neuraminidase inhibition antibody titers in influenza seroepidemiology.
    J Infect Dis. 2018 Jul 14. pii: 5053899. doi: 10.1093.
    PubMed     Text format    


  64. ZHOU X, Wang Y, Liu H, Guo F, et al
    Effectiveness of market-level biosecurity at reducing exposure of poultry and humans to avian influenza: a systematic review and meta-analysis.
    J Infect Dis. 2018 Jul 7. pii: 5050226. doi: 10.1093.
    PubMed     Text format     Abstract available


  65. PETRIE JG, Lauring AS
    Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?
    J Infect Dis. 2018 Jul 5. pii: 5049176. doi: 10.1093.
    PubMed     Text format    


    June 2018
  66. LIU F, Tzeng WP, Horner L, Kamal RP, et al
    Both Immune Priming and Egg-adaptation in the Vaccine Influence Antibody Responses to Circulating A(H1N1)pdm09 Viruses Following Influenza Vaccination in Adults.
    J Infect Dis. 2018 Jun 21. pii: 5042019. doi: 10.1093.
    PubMed     Text format     Abstract available


  67. KORMUTH KA, Lin K, Prussin AJ 2nd, Vejerano EP, et al
    Influenza Virus Infectivity Is Retained in Aerosols and Droplets Independent of Relative Humidity.
    J Infect Dis. 2018 Jun 7. pii: 5025997. doi: 10.1093.
    PubMed     Text format     Abstract available


  68. HOULIHAN C, Frampton D, Ferns RB, Raffle J, et al
    The use of whole genome sequencing in the investigation of a nosocomial influenza virus outbreak.
    J Infect Dis. 2018 Jun 5. pii: 5033093. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  69. VANDERVEN HA, Wragg K, Ana-Sosa-Batiz F, Kristensen AB, et al
    Anti-influenza Hyperimmune Immunoglobulin Enhances Fc-functional Antibody Immunity during Human Influenza Infection.
    J Infect Dis. 2018 May 31. pii: 5026129. doi: 10.1093.
    PubMed     Text format     Abstract available


  70. GUAN W, Wu NC, Lee HHY, Li Y, et al
    Clinical Correlations of Transcriptional Profile in Patients Infected with Avian Influenza H7N9 Virus.
    J Infect Dis. 2018 May 28. pii: 5017262. doi: 10.1093.
    PubMed     Text format     Abstract available


  71. VON MOLLENDORF C, Hellferscee O, Valley-Omar Z, Treurnicht FK, et al
    Influenza viral shedding in a prospective cohort of HIV-infected and -uninfected children and adults in 2 provinces of South Africa, 2012-2014.
    J Infect Dis. 2018 May 24. pii: 5002738. doi: 10.1093.
    PubMed     Text format     Abstract available


  72. RICHARDS KA, Treanor JJ, Nayak JL, Sant AJ, et al
    Overarching Immunodominance Patterns and Substantial Diversity in Specificity and Functionality in the Circulating Human Influenza A and B CD4 T Cell Repertoire.
    J Infect Dis. 2018 May 12. pii: 4995466. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. CHAN KF, Carolan LA, Korenkov D, Druce J, et al
    Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection.
    J Infect Dis. 2018 May 8. pii: 4994087. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  74. CARROLL TD, Jegaskanda S, Matzinger SR, Fritts L, et al
    A lipid/DNA adjuvant-inactivated influenza virus vaccine protects rhesus macaques from uncontrolled virus replication after heterosubtypic influenza A virus challenge.
    J Infect Dis. 2018 Apr 26. pii: 4986227. doi: 10.1093.
    PubMed     Text format     Abstract available


  75. DE VRIES RD, Altenburg AF, Nieuwkoop NJ, de Bruin E, et al
    Induction of Cross-Clade Antibody and T-Cell Responses by an MVA-Based Influenza H5N1 Vaccine in a Randomized Phase I/IIa Clinical Trial.
    J Infect Dis. 2018 Apr 18. pii: 4975691. doi: 10.1093.
    PubMed     Text format     Abstract available


  76. BORGOGNA TR, Hisey B, Heitmann E, Obar JJ, et al
    Secondary Bacterial Pneumonia by Staphylococcus aureus following Influenza A Infection Is SaeR/S Dependent.
    J Infect Dis. 2018 Apr 13. pii: 4970008. doi: 10.1093.
    PubMed     Text format     Abstract available


  77. VAN DE SANDT CE, Sagong KA, Pronk MR, Bestebroer TM, et al
    H1N1pdm09 Influenza Virus and its Descendants Lack Extra-Epitopic Amino Acid Residues Associated with Reduced Recognition by M158-66-specific CD8+ T-cells.
    J Infect Dis. 2018 Apr 12. pii: 4969428. doi: 10.1093.
    PubMed     Text format     Abstract available


  78. WANG Y, Guo Q, Yan Z, Zhou D, et al
    Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection.
    J Infect Dis. 2018 Apr 10. pii: 4965883. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  79. POLACK FP
    Crafting Live-Attenuated Vaccines Against Respiratory Syncytial Virus.
    J Infect Dis. 2018 Mar 2. pii: 4917537. doi: 10.1093.
    PubMed     Text format    


  80. BUCHHOLZ UJ, Cunningham CK, Muresan P, Gnanashanmugam D, et al
    Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.
    J Infect Dis. 2018 Mar 2. pii: 4917539. doi: 10.1093.
    PubMed     Text format     Abstract available


  81. MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
    Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children.
    J Infect Dis. 2018 Mar 2. pii: 4917538. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  82. ERBELDING EJ, Post D, Stemmy E, Roberts PC, et al
    A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.
    J Infect Dis. 2018 Feb 28. pii: 4904047. doi: 10.1093.
    PubMed     Text format     Abstract available


  83. YOUNG-XU Y, Van Aalst R, Mahmud SM, Rothman KJ, et al
    Relative Vaccine Effectiveness of High-Dose versus Standard-Dose Influenza Vaccines among Veterans Health Administration Patients.
    J Infect Dis. 2018 Feb 14. pii: 4858294. doi: 10.1093.
    PubMed     Text format     Abstract available


  84. XIANG D, Shen X, Pu Z, Irwin DM, et al
    Convergent Evolution of Human-Isolated H7N9 Avian Influenza A Viruses.
    J Infect Dis. 2018 Feb 9. pii: 4846861. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  85. MAEMURA T, Fukuyama S, Sugita Y, Lopes TJS, et al
    Lung-derived exosomal miR-483-3p regulates the innate immune response to influenza virus infection.
    J Infect Dis. 2018 Jan 24. pii: 4823229. doi: 10.1093.
    PubMed     Text format     Abstract available


  86. CHENG AC, Subbarao K
    Epidemiological Data on the Effectiveness of Influenza Vaccine-Another Piece of the Puzzle.
    J Infect Dis. 2018 Jan 18. pii: 4816917. doi: 10.1093.
    PubMed     Text format    


  87. FLANNERY B, Smith C, Garten RJ, Levine MZ, et al
    Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.
    J Infect Dis. 2018 Jan 18. pii: 4816916. doi: 10.1093.
    PubMed     Text format     Abstract available


  88. ZHU L, Liu L, Zhang Y, Pu L, et al
    High Level of Neutrophil Extracellular Traps Correlates With Poor Prognosis of Severe Influenza A Infection.
    J Infect Dis. 2018;217:428-437.
    PubMed     Text format     Abstract available


  89. STORCH GA
    Respiratory Viruses in Babies: Important Insights From Down Under.
    J Infect Dis. 2018;217:350-352.
    PubMed     Text format    


  90. CHIU SS, Kwan MYW, Feng S, Wong JSC, et al
    Influenza vaccine effectiveness against influenza A(H3N2) hospitalizations in children in Hong Kong in a prolonged season, 2016/17.
    J Infect Dis. 2018 Jan 16. pii: 4810661. doi: 10.1093.
    PubMed     Text format     Abstract available


  91. ROLFES MA, Gross FL, Flannery B, Meyers AFA, et al
    Kinetics of serological responses in critically ill patients hospitalized with influenza A(H1N1)pdm09 virus infection in Canada, 2009-2011.
    J Infect Dis. 2018 Jan 12. pii: 4803439. doi: 10.1093.
    PubMed     Text format     Abstract available


  92. DE WIT E, Siegers J, Cronin JM, Weatherman S, et al
    1918 H1N1 influenza virus replicates and induces pro-inflammatory cytokine responses in extra-respiratory tissues of ferrets.
    J Infect Dis. 2018 Jan 10. pii: 4796831. doi: 10.1093.
    PubMed     Text format     Abstract available


  93. LAURIE KL, Horman W, Carolan LA, Chan KF, et al
    Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.
    J Infect Dis. 2018 Jan 6. pii: 4792826. doi: 10.1093.
    PubMed     Text format     Abstract available


  94. GOLDSTEIN E, Nguyen HH, Liu P, Viboud C, et al
    On the Relative Role of Different Age Groups During Epidemics Associated With Respiratory Syncytial Virus.
    J Infect Dis. 2018;217:238-244.
    PubMed     Text format     Abstract available


    December 2017
  95. RAMILO O, Rodriguez-Fernandez R, Mejias A
    One Step Forward in the Road Toward a Universal Influenza Vaccine.
    J Infect Dis. 2017;217:1-2.
    PubMed     Text format    


  96. DE VRIES RD, Nieuwkoop NJ, van der Klis FRM, Koopmans MPG, et al
    Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity.
    J Infect Dis. 2017;217:3-11.
    PubMed     Text format     Abstract available


  97. CAPELLA C, Chaiwatpongsakorn S, Gorrell E, Risch ZA, et al
    Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection.
    J Infect Dis. 2017;216:1398-1406.
    PubMed     Text format     Abstract available


  98. MADARAS-KELLY K, Remington R, Hruza H, Xu D, et al
    The Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines in Preventing Post-Influenza Deaths.
    J Infect Dis. 2017 Dec 9. pii: 4718125. doi: 10.1093.
    PubMed     Text format    


  99. YOUNG B, Sadarangani S, Jiang L, Wilder-Smith A, et al
    The Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis and Meta-regression of Test-Negative Design Case-control Studies.
    J Infect Dis. 2017 Dec 6. pii: 4694421. doi: 10.1093.
    PubMed     Text format     Abstract available


  100. OHFUJI S, Deguchi M, Tachibana D, Koyama M, et al
    Protective effect of maternal influenza vaccination on influenza in their infants: a prospective cohort study.
    J Infect Dis. 2017 Dec 5. pii: 4693945. doi: 10.1093.
    PubMed     Text format     Abstract available


  101. LIU WC, Lin CS, Yeh CC, Wu HY, et al
    Effect of Influenza Vaccination Against Postoperative Pneumonia and Mortality for Geriatric Patients Receiving Major Surgery: A Nationwide Matched Study.
    J Infect Dis. 2017 Dec 5. pii: 4690590. doi: 10.1093.
    PubMed     Text format     Abstract available


  102. WAGHMARE A, Xie H, Kimball L, Yi J, et al
    Supplemental Oxygen-Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus.
    J Infect Dis. 2017;216:1235-1244.
    PubMed     Text format     Abstract available


    November 2017
  103. MAKVANDI-NEJAD S, Laurenson-Schafer H, Wang L, Wellington D, et al
    Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
    J Infect Dis. 2017 Nov 30. pii: 4676001. doi: 10.1093.
    PubMed     Text format     Abstract available


  104. LU X, Schneider E, Jain S, Bramley AM, et al
    Rhinovirus Viremia in Patients Hospitalized With Community-Acquired Pneumonia.
    J Infect Dis. 2017;216:1104-1111.
    PubMed     Text format     Abstract available


  105. KISO M, Lopes TJS, Yamayoshi S, Ito M, et al
    Combination Therapy with Neuraminidase and Polymerase Inhibitors in Nude Mice Infected with Influenza Virus.
    J Infect Dis. 2017 Nov 25. pii: 4662841. doi: 10.1093.
    PubMed     Text format     Abstract available


  106. MARIANI TJ, Qiu X, Chu C, Wang L, et al
    Association of Dynamic Changes in the CD4 T-Cell Transcriptome With Disease Severity During Primary Respiratory Syncytial Virus Infection in Young Infants.
    J Infect Dis. 2017;216:1027-1037.
    PubMed     Text format     Abstract available


  107. SEON SH, Choi JA, Yang E, Pyo S, et al
    Intranasal Immunization with an Attenuated Pep27 Mutant Provides Protection from Influenza Virus and Secondary Pneumococcal Infections.
    J Infect Dis. 2017 Nov 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  108. WONG SS, Oshansky CM, Guo XJ, Ralston J, et al
    Severe influenza is characterized by prolonged immune activation: results from the SHIVERS cohort study.
    J Infect Dis. 2017 Nov 3. doi: 10.1093.
    PubMed     Text format     Abstract available


  109. VANDERVEN HA, Jegaskanda S, Wines BD, Hogarth PM, et al
    Antibody-dependent cellular cytotoxicity (ADCC) responses to seasonal influenza vaccination in older adults.
    J Infect Dis. 2017 Nov 2. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  110. SKOWRONSKI DM, Chambers C, De Serres G
    Selection bias in the assessment of frailty and its role in influenza vaccine effectiveness evaluation among elderly adults.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    PubMed     Text format    


  111. SKOWRONSKI DM, Chambers C, Sabaiduc S, De Serres G, et al
    Beyond antigenic match: possible agent-host and immuno-epidemiological influences on influenza vaccine effectiveness during the 2015-16 season in Canada.
    J Infect Dis. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  112. BELONGIA E
    Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness.
    J Infect Dis. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format    


  113. OXMAN MN, Harbecke R, Koelle DM
    Clinical Usage of the Candidate Adjuvanted HZ/su Zoster Vaccine: re-vaccination of recipients of live attenuated zoster vaccine and co-administration with a seasonal influenza vaccine.
    J Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format    


  114. SCHWARZ TF, Aggarwal N, Moeckesch B, Schenkenberger I, et al
    Immunogenicity and safety of an adjuvanted herpes zoster subunit vaccine co-administered with seasonal influenza vaccine in adults aged 50 years and older.
    J Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  115. FALLOON J, Yu J, Esser MT, Villafana T, et al
    An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  116. LANGLEY JM
    Vaccine Prevention of Respiratory Syncytial Virus in Older Adults: The Work Continues.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format    


  117. WIDDOWSON MA, Bresee JS, Jernigan DB
    The Global Threat of Animal Influenza Viruses of Zoonotic Concern: Then and Now.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  118. LIU B, Havers FP, Zhou L, Zhong H, et al
    Clusters of Human Infections With Avian Influenza A(H7N9) Virus in China, March 2013 to June 2015.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  119. LIU F, Veguilla V, Gross FL, Gillis E, et al
    Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  120. HAVERS FP, Campbell AP, Uyeki TM, Fry AM, et al
    Commentary: A Historical Review of Centers for Disease Control and Prevention Antiviral Treatment and Postexposure Chemoprophylaxis Guidance for Human Infections With Novel Influenza A Viruses Associated With Severe Human Disease.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  121. CHAKRABORTY A, Rahman M, Hossain MJ, Khan SU, et al
    Mild Respiratory Illness Among Young Children Caused by Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in Dhaka, Bangladesh, 2011.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  122. VENTER M, Treurnicht FK, Buys A, Tempia S, et al
    Risk of Human Infections With Highly Pathogenic H5N2 and Low Pathogenic H7N1 Avian Influenza Strains During Outbreaks in Ostriches in South Africa.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  123. CREANGA A, Hang NLK, Cuong VD, Nguyen HT, et al
    Highly Pathogenic Avian Influenza A(H5N1) Viruses at the Animal-Human Interface in Vietnam, 2003-2010.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  124. LEVINE MZ, Holiday C, Liu F, Jefferson S, et al
    Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  125. GUBAREVA LV, Sleeman K, Guo Z, Yang H, et al
    Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  126. PULIT-PENALOZA JA, Simpson N, Yang H, Creager HM, et al
    Assessment of Molecular, Antigenic, and Pathological Features of Canine Influenza A(H3N2) Viruses That Emerged in the United States.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  127. JONES EN, Amoah S, Cao W, Sambhara S, et al
    An Adjuvanted A(H5N1) Subvirion Vaccine Elicits Virus-Specific Antibody Response and Improves Protection Against Lethal Influenza Viral Challenge in Mouse Model of Protein Energy Malnutrition.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  128. BELSER JA, Creager HM, Zeng H, Maines TR, et al
    Pathogenesis, Transmissibility, and Tropism of a Highly Pathogenic Avian Influenza A(H7N7) Virus Associated With Human Conjunctivitis in Italy, 2013.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  129. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
    Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada.
    J Infect Dis. 2017;216:697-702.
    PubMed     Text format     Abstract available


  130. SCHLABERG R, Ampofo K, Tardif KD, Stockmann C, et al
    Human Bocavirus Capsid Messenger RNA Detection in Children With Pneumonia.
    J Infect Dis. 2017;216:688-696.
    PubMed     Text format     Abstract available


  131. DUNKLE LM, Izikson R, Patriarca PA, Goldenthal KL, et al
    Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age.
    J Infect Dis. 2017 Sep 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  132. KISO M, Iwatsuki-Horimoto K, Yamayoshi S, Uraki R, et al
    Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques.
    J Infect Dis. 2017;216:582-593.
    PubMed     Text format     Abstract available


    August 2017
  133. NEUZIL KM, Chen WH
    Influenza Vaccines for Older Persons: Progress and Pitfalls.
    J Infect Dis. 2017;216:397-398.
    PubMed     Text format    


  134. ANDREW MK, Shinde V, Ye L, Hatchette T, et al
    The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.
    J Infect Dis. 2017;216:405-414.
    PubMed     Text format     Abstract available


  135. VAN BEEK J, Veenhoven RH, Bruin JP, van Boxtel RAJ, et al
    Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination in a Cohort of Older Adults, Despite Effectively Reducing Laboratory-Confirmed Influenza Virus Infections.
    J Infect Dis. 2017;216:415-424.
    PubMed     Text format     Abstract available


  136. MCELHANEY JE, McNeil SA
    Test-Negative Design: The Importance of Laboratory-Confirmed Illness in Estimating the Effectiveness of Influenza Vaccine in Older Adults.
    J Infect Dis. 2017;216:399-401.
    PubMed     Text format    


  137. MIDGLEY CM, Haynes AK, Baumgardner JL, Chommanard C, et al
    Determining the Seasonality of Respiratory Syncytial Virus in the United States: The Impact of Increased Molecular Testing.
    J Infect Dis. 2017;216:345-355.
    PubMed     Text format     Abstract available


    July 2017
  138. YOON SW, Wong SS, Zhu H, Chen R, et al
    Dysregulated T-Helper Type 1 (Th1):Th2 Cytokine Profile and Poor Immune Response in Pregnant Ferrets Infected With 2009 Pandemic Influenza A(H1N1) Virus.
    J Infect Dis. 2017 Jul 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  139. MOE N, Stenseng IH, Krokstad S, Christensen A, et al
    The Burden of Human Metapneumovirus and Respiratory Syncytial Virus Infections in Hospitalized Norwegian Children.
    J Infect Dis. 2017;216:110-116.
    PubMed     Text format     Abstract available


    June 2017
  140. PAULES CI, Lakdawala S, McAuliffe JM, Paskel M, et al
    An HA stem antibody MEDI8852 prevents and controls disease and limits transmission of pandemic influenza viruses.
    J Infect Dis. 2017 Jun 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  141. SHORT KR, Veeris R, Leijten LM, van den Brand JM, et al
    Proinflammatory Cytokine Responses in Extra-Respiratory Tissues During Severe Influenza.
    J Infect Dis. 2017 Jun 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  142. MONTO AS, Malosh RE, Petrie JG, Martin ET, et al
    The Doctrine of Original Antigenic Sin: Separating Good From Evil.
    J Infect Dis. 2017;215:1782-1788.
    PubMed     Text format     Abstract available


  143. CHUNG JR, Flannery B, Zimmerman RK, Nowalk MP, et al
    Prior season vaccination and risk of influenza during the 2014-2015 season in the U.S.
    J Infect Dis. 2017 Jun 13. doi: 10.1093.
    PubMed     Text format    


  144. DATTA S, Walsh EE, Peterson DR, Falsey AR, et al
    Can Analysis of Routine Viral Testing Provide Accurate Estimates of Respiratory Syncytial Virus Disease Burden in Adults?
    J Infect Dis. 2017;215:1706-1710.
    PubMed     Text format     Abstract available


    May 2017
  145. RANDOLPH AG, Yip WK, Allen EK, Rosenberger CM, et al
    Evaluation of IFITM3 rs12252 Association with Severe Pediatric Influenza Infection.
    J Infect Dis. 2017 May 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  146. LEE N, Cao B, Ke C, Lu H, et al
    IFITM3, TLR3, and CD55 Genes SNPs and Cumulative Ge-netic Risks for Severe Outcomes in Chinese Patients with H7N9 / H1N1pdm09 Influenza.
    J Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  147. HIROSE R, Nakaya T, Naito Y, Daidoji T, et al
    Mechanism of human influenza virus RNA persistence and virion survival in feces: mucus protects virions from acid and digestive juices.
    J Infect Dis. 2017 May 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  148. AGUAYO-HIRALDO PI, Arasaratnam RJ, Tzannou I, Kuvalekar M, et al
    Characterizing the cellular immune response to Parainfluenza virus 3.
    J Infect Dis. 2017 May 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  149. WAGHMARE A, Englund JA, Boeckh M
    Parainfluenza Virus 3-specific T Cells: Opportunity for Intervention?
    J Infect Dis. 2017 May 2. doi: 10.1093.
    PubMed     Text format    


  150. SCHLABERG R, Queen K, Simmon K, Tardif K, et al
    Viral Pathogen Detection by Metagenomics and Pan-Viral Group Polymerase Chain Reaction in Children With Pneumonia Lacking Identifiable Etiology.
    J Infect Dis. 2017;215:1407-1415.
    PubMed     Text format     Abstract available


    April 2017
  151. THWAITES RS, Ito K, Chingono JMS, Coates M, et al
    Nasosorption as a Minimally Invasive Sampling Procedure: Mucosal Viral Load and Inflammation in Primary RSV Bronchiolitis.
    J Infect Dis. 2017;215:1240-1244.
    PubMed     Text format     Abstract available


  152. HUANG X, Mengersen K, Milinovich G, Hu W, et al
    Effect of weather variability on seasonal influenza among different age groups in Queensland, Australia: A Bayesian spatiotemporal analysis.
    J Infect Dis. 2017 Apr 12. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  153. MOHN KG, Zhou F, Brokstad KA, Sridhar S, et al
    Live attenuated influenza vaccination boosts durable cross-reactive and protection-associated T-cells in children.
    J Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  154. PETRIE JG, Monto AS
    Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
    J Infect Dis. 2017;215:841-843.
    PubMed     Text format    


  155. MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
    Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus.
    J Infect Dis. 2017;215:847-855.
    PubMed     Text format     Abstract available


  156. SHAY DK, Chillarige Y, Kelman J, Forshee RA, et al
    Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014.
    J Infect Dis. 2017 Mar 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  157. MONTO AS
    Moving Toward Improved Influenza Vaccines.
    J Infect Dis. 2017 Mar 2. doi: 10.1093.
    PubMed     Text format    


  158. CASERTA MT, Qiu X, Tesini B, Wang L, et al
    Development of a Global Respiratory Severity Score for Respiratory Syncytial Virus Infection in Infants.
    J Infect Dis. 2017;215:750-756.
    PubMed     Text format     Abstract available


    February 2017
  159. LIU L, Nachbagauer R, Zhu L, Huang Y, et al
    Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.
    J Infect Dis. 2017;215:518-528.
    PubMed     Text format     Abstract available


  160. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
    Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-11 to 2014-15.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  161. BOECKH M, Stevens-Ayers T, Travi G, Huang ML, et al
    Bronchoalveolar Lavage DNA Quantification in Cytomegalovirus Pneumonia after Hematopoietic Cell Transplantation.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  162. PETRIE JG, Monto AS
    Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


  163. MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
    Effect of Repeated Vaccination With the Same Vaccine Component Against Influenza A(H1N1)pdm09.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


    January 2017
  164. ARNOTT A, Carville K, Franklin L, Sullivan SG, et al
    Consecutive Influenza Infections in Both Adults and Children.
    J Infect Dis. 2017 Jan 18. doi: 10.1093.
    PubMed     Text format    


  165. HEIKKINEN T, Ojala E, Waris M
    Clinical and Socioeconomic Burden of Respiratory Syncytial Virus Infection in Children.
    J Infect Dis. 2017;215:17-23.
    PubMed     Text format     Abstract available


    December 2016
  166. EWING A, Lee EC, Viboud C, Bansal S, et al
    Contact, travel, and transmission: The impact of winter holidays on influenza dynamics in the United States.
    J Infect Dis. 2016 Dec 28. pii: jiw642. doi: 10.1093.
    PubMed     Text format     Abstract available


  167. HADLER JL
    Christmas-New Year influenza lull: not too late for vaccination.
    J Infect Dis. 2016 Dec 28. pii: jiw643. doi: 10.1093.
    PubMed     Text format    


  168. JEGASKANDA S, Co MD, Cruz J, Subbarao K, et al
    Human seasonal influenza A viruses induce H7N9-cross-reactive antibody-dependent cellular cytotoxicity (ADCC) antibodies that are directed towards the nucleoprotein.
    J Infect Dis. 2016 Dec 23. pii: jiw629. doi: 10.1093.
    PubMed     Text format     Abstract available


  169. TRIEU MC, Zhou F, Lartey S, Jul-Larsen A, et al
    Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination.
    J Infect Dis. 2016 Dec 22. pii: jiw619. doi: 10.1093.
    PubMed     Text format     Abstract available


  170. PETRIE JG, Parkhouse K, Ohmit SE, Malosh RE, et al
    Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains.
    J Infect Dis. 2016;214:1947-1951.
    PubMed     Text format     Abstract available


  171. SHIMIZU K, Wulandari L, Poetranto ED, Setyoningrum RA, et al
    Seroevidence for a High Prevalence of Subclinical Infection With Avian Influenza A(H5N1) Virus Among Workers in a Live-Poultry Market in Indonesia.
    J Infect Dis. 2016;214:1929-1936.
    PubMed     Text format     Abstract available


  172. FEDSON DS
    Statins, Influenza Vaccination and Influenza.
    J Infect Dis. 2016.
    PubMed     Text format    


  173. FEDSON DS
    Statins, Influenza Vaccination and Influenza.
    J Infect Dis. 2016 Dec 7. doi: 10.1093.
    PubMed     Text format    


    October 2016
  174. LIU WJ, Tan S, Zhao M, Quan C, et al
    Cross-Immunities against Avian Influenza H7N9 Virus in the Healthy Population Affected by Antigenicity-Dependent Substitutions.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  175. MORI I
    Vaccination Effectively Prevents Central Nervous System Invasion by Influenza A(H5N1) Virus Through the Olfactory Pathway: A Proposed Mechanism of Neuroprotection.
    J Infect Dis. 2016.
    PubMed     Text format    



  176. Live attenuated influenza vaccine in children induces B-cell responses in tonsils.
    J Infect Dis. 2016.
    PubMed     Text format    


    September 2016
  177. LANGLEY JM, Aggarwal N, Toma A, Halperin SA, et al
    A randomized, controlled, observer-blind Phase I study of the safety and immunogenicity of a Respiratory Syncytial Virus vaccine with or without alum adjuvant.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  178. LE GARS M, Kay AW, Bayless NL, Aziz N, et al
    Increased Pro-Inflammatory Responses of Monocytes and Plasmacytoid Dendritic Cells to Influenza A Virus Infection During Pregnancy.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  179. YU KO, Randolph AG, Agan AA, Yip WK, et al
    Staphylococcus aureus alpha-toxin Response Distinguishes Respiratory Virus-MRSA Co-infection in Children.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  180. MADAN A, Segall N, Ferguson M, Frenette L, et al
    Immunogenicity and safety of an AS03-adjuvanted H7N9 pandemic influenza vaccine in a randomized trial in healthy adults.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  181. HOFT DF, Lottenbach K, Goll JB, Hill H, et al
    Priming Vaccination with H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: